CompoAtlas

NW LabisiaG Capsule 580mg

NW LabisiaG Capsule 580mg : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
Labisia pumila (Kacip fatimah)Labisia pumila (Kacip fatimah)[280;mg;580;mg]Not identified
Allium Sativum.Allium Sativum.[300;mg;580;mg]Not identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
MAL15070013T
Type
Natural product
Published status
PRODUCT APPROVED
Licence holder
NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
Manufacturer
NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
Registration period starting
2025-09-08
Published validity end
2030-09-08

Original register data

View published fields and their variants
Active ingredients
Labisia pumila (Kacip fatimah)[280;mg;580;mg],Allium Sativum.[300;mg;580;mg]
Valid until
2030-09-08
Registration date
2025-09-08
Published description
NATURAL PRODUCT
Licence holder
NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
Producer
NATURAL WELLNESS INDUSTRIES SDN. BHD. (MILIK PENUH NUTRIVENTION SDN. BHD)
Published name
NW LabisiaG Capsule 580mg
Published reference
2014102203481
Registration number
MAL15070013T
Published status
PRODUCT APPROVED

Official source

View the official register, number MAL15070013T

Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0

CC BY 4.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Allium Sativum.
    Read the warning, when it applies and the studies cited

    Garlic - Allium sativum

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Relief of upper respiratory tract infections and catarrhal (nasal congestion) conditions.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: All uses.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners or protease inhibitors (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Brinker 2010; Mills and Bone 2005).

    Sources cited by Health Canada (2)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.

    Health Canada monograph dated 30 January 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “NW LabisiaG Capsule 580mg”, https://compoatlas.com/en/supplements/malaysia/MAL15070013T-nw-labisiag-capsule-580mg, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line